The Pasqual Maragall Foundation, which prompted the Barcelona\u03b2eta Brain Research Center (BBRC), is celebrating its 10th anniversary. With the aim to \u201cbring back\u201d memories to its founder Pasqual Maragall, who was diagnosed with Alzheimer\u2019s disease in 2007 and created the foundation one year later, the foundation launched a book in which 40 friends of the former mayor of Barcelona and president of Catalonia remember an anecdote with him. Part of the benefits of the book will go to the research on Alzheimer\u2019s prevention carried out at the BBRC. The book was presented the 20th of September in Barcelona, in an event with more than 600 attendants.<\/p>\n
Also coinciding with the World Alzheimer\u2019s Day, the Pasqual Maragall Foundation, together with \u201cla Caixa\u201d Banking Foundation, covered the names of the plaques of several streets in the \u00d3pera neighbourhood in Madrid. The aim of the street campaign was to raise awareness about the symptoms of Alzheimer\u2019s disease, such as disorientation, and the need to invest more money on research. You can see the video of the campaign here<\/a>.<\/p>\n Biogen (Baar, Switzerland)<\/b><\/span><\/p>\n This year, on World Alzheimer\u2019s Day and through World Alzheimer\u2019s Month, Biogen engaged in various educational and communications initiatives, to share the depth of commitment, passion and ambition of the people working in Alzheimer\u2019s. From research & development, medical and patient advocacy colleagues across the company delivered a message of defiance in bringing innovation to the Alzheimer\u2019s disease community. Specifically, Biogen partnered with the European Federation of Pharmaceutical Industries and Associations (EFPIA) to publish pledges committing to the clinical research and tackling of stigma in Alzheimer\u2019s disease. Throughout September Biogen also worked with RAND corporation to highlight health system readiness in Europe<\/a> to new Alzheimer\u2019s innovations. Outside of Europe, Biogen supported several of the Alzheimer\u2019s Association \u201cWalk to End Alzheimer\u2019s\u201d in the US. As a company Biogen is proud to demonstrate its commitment to the millions of people living with Alzheimer\u2019s disease and their loved ones.\u00a0Biogen has made a long-term commitment to furthering Alzheimer\u2019s disease research and treatment, and remains driven by the profound unmet needs of patients, families, caregivers and society.<\/span><\/p>\n CHUT (Toulouse, France)<\/strong><\/p>\n Together with the French Alzheimer association \u00ab\u00a0France Alzheimer\u00a0\u00bb of its department, the CHUT organised an event on World Alzheimer\u2019s Day entitled \u00abChangeons de regard pour comprendre et agir\u00a0\u00bb. Dr Pierre Jean Ousset gave a presentation on Alzheimer\u2019s disease. The programme could be downloaded here<\/a>.<\/p>\n CHRU (Lille, France)<\/strong><\/p>\n Several events were organised on World Alzheimer\u2019s Day in Lille including a meeting to celebrate the 25 years of the Bailleul advanced consultation. This meeting organised for the general public at the \u201ccentre m\u00e9dical des monts de flandres\u201d involved many CHRU\u2019s consultants. Moreover, CHRU had a great media coverage. TF1, the private national French TV channel considered as the most popular domestic network, diffused a TV reportage on their \u201ccentre de la m\u00e9moire\u201d.<\/p>\n IRCCS Fatebenefratelli (Brescia, Italy)<\/strong><\/p>\n As every year for the World Alzheimer’s Day, the well-known Millennium gym in Brescia – located in front of the Brescia\u2019s Institute \u201cIRCCS Centro San Giovanni di Dio Fatebenefratelli\u201d – organises an event called “Move for Alzheimer \/ Muoviamoci per l’Alzheimer” to raise funds and support research for Alzheimer’s disease. This year, the event lasted one week (September 13-21) and the program consisted of a series of sporting events aimed at the entire population, such as pole dance, soccer and yoga. During this occasion, some researchers of the IRCCS Fatebenefratelli took the opportunity to explain the research activity of the Institute at dedicated stands.<\/p>\n On September 21, an informational meeting aimed at patients and their relatives was also organised at the IRCCS Fatebenefratelli to increase the awareness on Alzheimer\u2019s disease and patient\u2019s care. The Chief Medical Officer, the director-General, a clinician and a qualified trainer of the institute had the opportunity to be speakers at this event.<\/p>\n Janssen (Beerse, Belgium)<\/strong><\/p>\n Each year on September 21, which marks World Alzheimer Day, an international campaign is being organised to raise awareness and challenge the stigma surrounding dementia. Janssen R&D Neuroscience organised several internal initiatives to bring attention to this disease. A fourth edition of the Janssen Talk Caf\u00e9 Dementia was hosted at Janssen Beerse, followed by a play about caregiving. For this edition, Janssen R&D Neuroscience focused on \u2018treatment of dementia \u2013 the key to success\u2019. In this interactive session, Janssen employees were invited to get more insight into what is known about Alzheimer\u2019s disease treatments. Additionally, cupcakes were sold to support Alzheimer’s research (Stichiting Alzheimer Onderzoek).<\/p>\n Karolinska Institutet (Stockholm, Sweden)<\/strong><\/p>\n On Sept 21st Karolinska Institutet and Theme Aging, Karolinska University Hospital, recognised the seventh World Alzheimer\u2019s Day. They took the opportunity to attend lectures from frontiers, among others Prof Miia Kivipelto and her team, within the field of Alzheimer prevention, diagnostics, and treatment. In a parallel event, sponsored by the Swedish Alzheimer Foundation, Associate Prof Alina Solomon gave a lecture regarding how we can prevent dementia and multi-domain interventions. After that, a joint visit to their new Memory Clinic at Karolinska University Hospital Solna was organised. During the evening of the same day Prof Kivipelto traveled to Helsinki, Finland to participate in the gala event of Alzheimer Association Finland. She received the first time ever gold medal awarded for her contributions for dementia prevention and patient care.<\/p>\n Paris Nord GH de Lariboisiere (Paris, France)<\/strong><\/p>\n For the World Alzheimer’s Day, France Alzheimer organised an event from 21st September to 23rd September in Paris. In the space of these three days, several topics were presented and discussed including adapted physical activities, prevention, early diagnosis, treatments, scientific research, nutrition and carers in professional activity. 33 hours of workshops and 17 presentations were planned on the occasion of the 6th edition of the \u201cAlzheimer Village\u201d. The program could be downloaded here<\/a>. We are glad to see that thee members of the Paris Nord GH de Lariboisiere contributed to this event. On 22nd September, Dr Julien Dumurgier and Aurelie Meauzoone gave a presentation about the early diagosis. Pr Claire Paquet reported about the frontotemporal degenerations and the Lewy body disease.<\/p>\n Tayside (Dundee, Scotland)<\/strong><\/p>\n In Tayside, the team had an exhibition stall promoting dementia research in the Clinical Research Centre at Ninewells Hospital in Dundee. In addition, there’s been some activity on their social media accounts.<\/p>\n UNIGE (Geneva, Switzerland)<\/strong><\/p>\n On the occasion of World Alzheimer\u2019s Day on September 21st 2018, a Geneva\u2019s Alzheimer day has been organised in the University Hospitals of Geneva (HUG), by the Swiss Association for Alzheimer\u2019s Research (APRA). The programme could be downloaded here. During this day, a series of talks took place in the presence of the officials of Geneva\u2019s city, among which a presentation of the Geneva Centre de la M\u00e9moire. During his presentation, Prof. Frisoni explained the role of the center as a central point of contact for patients and researchers and gave exposure to the research projects led in Geneva. To complete this day, a concert in favor of the APRA 30th birthday was given in order to unite the different stakeholders around a festive event.<\/p>\n History of World Alzheimer\u2019s Day<\/strong><\/p>\n World Alzheimer\u2019s Day (21st September) was launched in 1994 to mark the 10th anniversary of Alzheimer\u2019s disease International (ADI), who is the umbrella international organisation of 90 Alzheimer associations around the world.\u00a0 Originally, this day is part of World Alzheimer\u2019s Month, where organisations coordinate to create global messages about dementia for the media, key stakeholders and policy makers. ADI coordinates the World Alzheimer\u2019s Month campaign through their members, supporters and corporate partners. September 2018 marked the seventh World Alzheimer\u2019s Month campaign. Its primary objective is to reach out to as many countries as possible, showing the global impact of dementia and promoting dementia awareness and what we can do to help support those living with the disease. The theme for this year\u2019s World Alzheimer\u2019s Month campaign is Every 3 seconds. Every 3 seconds someone in the world develops dementia.<\/p>\n <\/p>\n <\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" World Alzheimer’s Month is the international campaign to raise awareness and challenge the stigma that surrounds dementia. September 2018 is World Alzheimer’s Month (WAM), including World Alzheimer’s Day (WAD) on 21 September.\u00a0 The 7th global WAM utilises the theme of \u201cEvery 3 seconds\u201d to emphasise the huge global impact of dementia worldwide. As every year […]<\/p>\n","protected":false},"author":1,"featured_media":2522,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-2512","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/2512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/comments?post=2512"}],"version-history":[{"count":0,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/2512\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media\/2522"}],"wp:attachment":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media?parent=2512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/categories?post=2512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/tags?post=2512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"\"](\"https:\/\/alzheimer.noemi.lu\/wp-content\/uploads\/2018\/09\/DnYTg6vWsAAQAVj-300x157.jpg\")
<\/a>![\"\"](\"https:\/\/alzheimer.noemi.lu\/wp-content\/uploads\/2018\/09\/DoLm6jDU4AAE2yp-300x157.jpg\")
<\/a><\/p>\n